In this Issue
Contextualizing the current landscape of data and devices.
Guest Chief Medical Editors’ Page
By Marianne Brodmann, MD, and William A. Gray, MD
Not all superficial femoral artery device trials are created equal—in fact, none are.
By William A. Gray, MD; and Mario Landini
Experts discuss key elements of SFA trials, whether a global algorithmic approach to treating SFA disease is possible, and the limitations of cross-trial platform comparisons.
Moderator: William A. Gray, MD
Panel: Gary M. Ansel, MD; Koen Deloose, MD; Michael R. Jaff, DO; and Peter A. Schneider, MD
An overview of the FDA’s new multistakeholder project to support real-world evidence evaluation for devices aimed at treating peripheral artery disease.
By Misti Malone, PhD
Understanding the FDA device approval process and the difference between data from premarket and postapproval trials to make informed clinical decisions.
By Gary M. Ansel, MD; and Raghu Kolluri, MD, RVT, RPVI
A discussion of anatomic barriers to treatment, evolving trial designs, and the impact of reimbursement.
By Krishna Rocha-Singh, MD
A discussion on the current role of vessel preparation, when to use it and when not to use it, device selection, and data related to cost-effectiveness and algorithm creation.
Moderator: Marianne Brodmann, MD
Panel: Ehrin J. Armstrong, MD; Lawrence A. Garcia, MD; Gunnar Tepe, MD; Jos C. van den Berg, MD, PhD; and Thomas Zeller, MD
Capabilities and limitations of current technologies and available data.
By Brian G. DeRubertis, MD, FACS
Appraising the current literature on bioresorbable technology use in the SFA, what can be learned from the coronary experience, and the future of bioresorbable stents in this anatomy.
By Sabine Steiner, MD; Andrej Schmidt, MD; and Dierk Scheinert, MD
A brief review of the Detour procedure technique, proposed advantages, and potential clinical applications.
By James D. Joye, DO, FACC, FSCAI
FEATURED TECHNOLOGYSponsored by ROX Medical
A discussion with Dr. Krishna Rocha-Singh and Prof. Dr. Felix Mahfoud on what makes the ROX Coupler device different from other hypertension interventions, how to implant the device, clinical study results, and anticipated results from ongoing studies.
With Krishna Rocha-Singh, MD; and Felix Mahfoud, MD
Discussion on the prevalence of post-angioplasty dissections, guidelines for their identification, and the use of the Tack Endovascular System® for repair.
With Ehrin J. Armstrong, MD, MSc; Nicolas W. Shammas, MD, MS, EJD; and Christian Wissgott, MD
MEDICAL AFFAIRS CORNERSponsored by Medtronic
By Gary M. Ansel, MD
Dr. Palena discusses the necessary skills for tackling challenging CLI cases, his ongoing research of new technology in this area, and his educational work around the world, particularly as Course Director of the CLIC meeting series.